Can Fite Biopharma Ltd's subsidiary ophthaliX signs definitive agreement to acquire Improved Vision Systems Ltd
Saturday, June 20, 2015
Can Fite Biopharma Ltd announced that its subsidiary, OphthaliX has signed a definitive agreement to acquire Israel-based Improved Vision Systems Ltd.Under the terms of the agreement, in exchange for I.V.S. becoming a wholly-owned subsidiary of OphthaliX.OphthaliX will issue to the sellers and option holders of I.V.S. at the initial closing such number of shares of OphthaliX common stock and OphthaliX options equal to an aggregate of about 14 pct. of the issued and outstanding capital stock of OphthaliX.In addition, OphthaliX has agreed to issue to the sellers and option holders of I.V.S. such number of shares of OphthaliX common stock and OphthaliX options equal to an aggregate of about 11 pct. of the issued and outstanding capital stock of OphthaliX.
reuters.com
